ELI LILLY & Co — Director's Dealing 2013

Mar 26, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2013-03-26

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-26	Common Stock	S	5000	$56.00	Disposed	47380	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1512	Indirect
Common Stock	1502	Indirect
Common Stock	6218	Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2013.

F2: Reporting person disclaims beneficial ownership of these shares.